{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T21:24:58Z","timestamp":1745961898650},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10557-020-07013-w","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T08:03:39Z","timestamp":1593849819000},"page":"1111-1127","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats"],"prefix":"10.1007","volume":"35","author":[{"given":"Feng-Yen","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Min","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Hurng","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Sung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"issue":"1","key":"7013_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOT.0000000000000370","volume":"22","author":"J Merola","year":"2017","unstructured":"Merola J, Jane-Wit DD, Pober JS. Recent advances in allograft vasculopathy. Curr Opin Organ Transplant. 2017;22(1):1\u20137.","journal-title":"Curr Opin Organ Transplant."},{"issue":"1","key":"7013_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOT.0b013e3283342780","volume":"15","author":"DS Nath","year":"2010","unstructured":"Nath DS, Basha HI, Mohanakumar T. Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection. Curr Opin Organ Transplant. 2010;15(1):16\u201320.","journal-title":"Curr Opin Organ Transplant"},{"issue":"1","key":"7013_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.healun.2012.09.030","volume":"32","author":"KP Daly","year":"2013","unstructured":"Daly KP, Seifert ME, Chandraker A, Zurakowski D, Nohria A, Givertz MM, et al. VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2013;32(1):120\u20138.","journal-title":"J Heart Lung Transplant"},{"key":"7013_CR4","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.2741\/2903","volume":"13","author":"MJ Weiss","year":"2008","unstructured":"Weiss MJ, Madsen JC, Rosengard BR, Allan JS. Mechanisms of chronic rejection in cardiothoracic transplantation. Front Biosci. 2008;13:2980\u20138.","journal-title":"Front Biosci"},{"issue":"2","key":"7013_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0012.2010.01307.x","volume":"25","author":"M Colvin-Adams","year":"2011","unstructured":"Colvin-Adams M, Agnihotri A. Cardiac allograft vasculopathy: current knowledge and future direction. Clin Transpl. 2011;25(2):175\u201384.","journal-title":"Clin Transpl"},{"issue":"3","key":"7013_CR6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","volume":"214","author":"R Mentlein","year":"1993","unstructured":"Mentlein R, Gallwitz B, Schmidt WE. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem. 1993;214(3):829\u201335.","journal-title":"Eur J Biochem"},{"issue":"6","key":"7013_CR7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s00125-005-1749-8","volume":"48","author":"E Mannucci","year":"2005","unstructured":"Mannucci E, Pala L, Ciani S, Bardini G, Pezzatini A, Sposato I, et al. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia. 2005;48(6):1168\u201372.","journal-title":"Diabetologia."},{"key":"7013_CR8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fendo.2019.00080","volume":"10","author":"CF Deacon","year":"2019","unstructured":"Deacon CF. Physiology and pharmacology of DPP-4 in glucose homeostasis and the treatment of type 2 diabetes. Front Endocrinol (Lausanne). 2019;10:80.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"7013_CR9","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","volume":"33","author":"GP Fadini","year":"2010","unstructured":"Fadini GP, Boscaro E, Albiero M, Menegazzo L, Frison V, de Kreutzenberg S, et al. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care. 2010;33(7):1607\u20139.","journal-title":"Diabetes Care"},{"issue":"7","key":"7013_CR10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/ATVBAHA.110.206425","volume":"30","author":"H Oeseburg","year":"2010","unstructured":"Oeseburg H, de Boer RA, Buikema H, van der Harst P, van Gilst WH, Sillje HH. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase a. Arterioscler Thromb Vasc Biol. 2010;30(7):1407\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"7013_CR11","doi-asserted-by":"crossref","first-page":"E1209","DOI":"10.1152\/ajpendo.00237.2004","volume":"287","author":"T Nystrom","year":"2004","unstructured":"Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahren B, et al. Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab. 2004;287(6):E1209\u201315.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"7","key":"7013_CR12","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1476-5381.2012.02102.x","volume":"167","author":"CY Huang","year":"2012","unstructured":"Huang CY, Shih CM, Tsao NW, Lin YW, Huang PH, Wu SC, et al. Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells. Br J Pharmacol. 2012;167(7):1506\u201319.","journal-title":"Br J Pharmacol"},{"issue":"17","key":"7013_CR13","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2174\/09298673113206660273","volume":"21","author":"CM Shih","year":"2014","unstructured":"Shih CM, Chen YH, Lin YW, Tsao NW, Wu SC, Kao YT, et al. MK-0626, a dipeptidyl peptidase-4 inhibitor, improves neovascularization by increasing both the number of circulating endothelial progenitor cells and endothelial nitric oxide synthetase expression. Curr Med Chem. 2014;21(17):2012\u201322.","journal-title":"Curr Med Chem"},{"issue":"4","key":"7013_CR14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jvs.2016.05.093","volume":"66","author":"HY Lu","year":"2017","unstructured":"Lu HY, Huang CY, Shih CM, Lin YW, Tsai CS, Lin FY, et al. A potential contribution of dipeptidyl peptidase-4 by the mediation of monocyte differentiation in the development and progression of abdominal aortic aneurysms. J Vasc Surg. 2017;66(4):1217\u201326 e1.","journal-title":"J Vasc Surg"},{"key":"7013_CR15","doi-asserted-by":"crossref","first-page":"606031","DOI":"10.1155\/2015\/606031","volume":"2015","author":"J Zhong","year":"2015","unstructured":"Zhong J, Gong Q, Goud A, Srinivasamaharaj S, Rajagopalan S. Recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials. J Diabetes Res. 2015;2015:606031.","journal-title":"J Diabetes Res"},{"issue":"9","key":"7013_CR16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/TP.0b013e3181efcfbc","volume":"90","author":"DS Bedi","year":"2010","unstructured":"Bedi DS, Riella LV, Tullius SG, Chandraker A. Animal models of chronic allograft injury: contributions and limitations to understanding the mechanism of long-term graft dysfunction. Transplantation. 2010;90(9):935\u201344.","journal-title":"Transplantation."},{"issue":"1","key":"7013_CR17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.CIR.100.1.67","volume":"100","author":"RS Poston","year":"1999","unstructured":"Poston RS, Billingham M, Hoyt EG, Pollard J, Shorthouse R, Morris RE, et al. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model. Circulation. 1999;100(1):67\u201374.","journal-title":"Circulation."},{"issue":"6","key":"7013_CR18","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/db06-1103","volume":"56","author":"YH Chen","year":"2007","unstructured":"Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes. 2007;56(6):1559\u201368.","journal-title":"Diabetes."},{"issue":"4973","key":"7013_CR19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.2204114","volume":"249","author":"S Goldstein","year":"1990","unstructured":"Goldstein S. Replicative senescence: the human fibroblast comes of age. Science. 1990;249(4973):1129\u201333.","journal-title":"Science."},{"issue":"23","key":"7013_CR20","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1073\/pnas.85.23.9086","volume":"85","author":"SW Sherwood","year":"1988","unstructured":"Sherwood SW, Rush D, Ellsworth JL, Schimke RT. Defining cellular senescence in IMR-90 cells: a flow cytometric analysis. Proc Natl Acad Sci U S A. 1988;85(23):9086\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"7013_CR21","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92(20):9363\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"7013_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.yjmcc.2003.10.005","volume":"36","author":"JZ Chen","year":"2004","unstructured":"Chen JZ, Zhu JH, Wang XX, Xie XD, Sun J, Shang YP, et al. Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood. J Mol Cell Cardiol. 2004;36(2):233\u20139.","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"7013_CR23","first-page":"525","volume":"22","author":"TT Khan","year":"2011","unstructured":"Khan TT, Mirza AB, Zahid R, Haleem A, Al Hussaini H, Al Sulaiman M, et al. Antibody-mediated rejection: importance of lactate dehydrogenase and neutrophilia in early diagnosis. Saudi J Kidney Dis Transpl. 2011;22(3):525\u201330.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"10","key":"7013_CR24","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/01.tp.0000263338.39555.21","volume":"83","author":"S Arora","year":"2007","unstructured":"Arora S, Gullestad L, Wergeland R, Simonsen S, Holm T, Hognestad A, et al. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Transplantation. 2007;83(10):1308\u201315.","journal-title":"Transplantation."},{"key":"7013_CR25","first-page":"3094642","volume":"2016","author":"YS Lee","year":"2016","unstructured":"Lee YS, Jun HS. Anti-inflammatory effects of GLP-1-based therapies beyond glucose control. Mediat Inflamm. 2016;2016:3094642.","journal-title":"Mediat Inflamm"},{"issue":"9","key":"7013_CR26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","volume":"84","author":"GJ Kato","year":"2009","unstructured":"Kato GJ, Hebbel RP, Steinberg MH, Gladwin MT. Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol. 2009;84(9):618\u201325.","journal-title":"Am J Hematol"},{"issue":"9","key":"7013_CR27","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.ATV.0000237750.44469.88","volume":"26","author":"GP Fadini","year":"2006","unstructured":"Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol. 2006;26(9):2140\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2\u20133","key":"7013_CR28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.trim.2011.07.001","volume":"25","author":"M Huibers","year":"2011","unstructured":"Huibers M, De Jonge N, Van Kuik J, Koning ES, Van Wichen D, Dullens H, et al. Intimal fibrosis in human cardiac allograft vasculopathy. Transpl Immunol. 2011;25(2\u20133):124\u201332.","journal-title":"Transpl Immunol"},{"issue":"4","key":"7013_CR29","first-page":"395","volume":"40","author":"JP Costello","year":"2013","unstructured":"Costello JP, Mohanakumar T, Nath DS. Mechanisms of chronic cardiac allograft rejection. Tex Heart Inst J. 2013;40(4):395\u20139.","journal-title":"Tex Heart Inst J"},{"issue":"3","key":"7013_CR30","first-page":"229","volume":"6","author":"I Kaczmarek","year":"2008","unstructured":"Kaczmarek I, Deutsch MA, Kauke T, Beiras-Fernandez A, Schmoeckel M, Vicol C, et al. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant. Exp Clin Transplant. 2008;6(3):229\u201335.","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"7013_CR31","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11936-013-0278-x","volume":"16","author":"RD Benatti","year":"2014","unstructured":"Benatti RD, Taylor DO. Evolving concepts and treatment strategies for cardiac allograft vasculopathy. Curr Treat Options Cardiovasc Med. 2014;16(1):278.","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"10","key":"7013_CR32","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/TP.0b013e3182157d60","volume":"91","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Cecka JM, Gjertson DW, Ge P, Rose ML, Patel JK, et al. HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation. 2011;91(10):1153\u20138.","journal-title":"Transplantation."},{"issue":"8","key":"7013_CR33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/ATVBAHA.114.302818","volume":"34","author":"JS Pober","year":"2014","unstructured":"Pober JS, Jane-wit D, Qin L, Tellides G. Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy. Arterioscler Thromb Vasc Biol. 2014;34(8):1609\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"7013_CR34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3325\/cmj.2014.55.562","volume":"55","author":"B Skoric","year":"2014","unstructured":"Skoric B, Cikes M, Ljubas Macek J, Baricevic Z, Skorak I, Gasparovic H, et al. Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis. Croat Med J. 2014;55(6):562\u201376.","journal-title":"Croat Med J"},{"issue":"9","key":"7013_CR35","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/thx.2008.104133","volume":"64","author":"LA Borthwick","year":"2009","unstructured":"Borthwick LA, Parker SM, Brougham KA, Johnson GE, Gorowiec MR, Ward C, et al. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax. 2009;64(9):770\u20137.","journal-title":"Thorax."},{"issue":"6","key":"7013_CR36","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.celrep.2012.10.021","volume":"2","author":"PY Chen","year":"2012","unstructured":"Chen PY, Qin L, Barnes C, Charisse K, Yi T, Zhang X, et al. FGF regulates TGF-beta signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep. 2012;2(6):1684\u201396.","journal-title":"Cell Rep"},{"issue":"Suppl 1","key":"7013_CR37","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1755-1536-5-S1-S7","volume":"5","author":"S Piera-Velazquez","year":"2012","unstructured":"Piera-Velazquez S, Jimenez SA. Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases. Fibrogenesis Tissue Repair. 2012;5(Suppl 1):S7.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"4","key":"7013_CR38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1053-2498(03)00222-5","volume":"23","author":"C Atkinson","year":"2004","unstructured":"Atkinson C, Horsley J, Rhind-Tutt S, Charman S, Phillpotts CJ, Wallwork J, et al. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant. 2004;23(4):427\u201335.","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"7013_CR39","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.111.259960","volume":"110","author":"A von Gise","year":"2012","unstructured":"von Gise A, Pu WT. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res. 2012;110(12):1628\u201345.","journal-title":"Circ Res"},{"issue":"7","key":"7013_CR40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","volume":"348","author":"JM Hill","year":"2003","unstructured":"Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593\u2013600.","journal-title":"N Engl J Med"},{"issue":"11","key":"7013_CR41","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCRESAHA.109.207266","volume":"105","author":"DA D'Alessandro","year":"2009","unstructured":"D'Alessandro DA, Kajstura J, Hosoda T, Gatti A, Bello R, Mosna F, et al. Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart. Circ Res. 2009;105(11):1128\u201340.","journal-title":"Circ Res"},{"issue":"3","key":"7013_CR42","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/01.ATV.0000059337.60393.64","volume":"23","author":"JL Hillebrands","year":"2003","unstructured":"Hillebrands JL, Klatter FA, Rozing J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler Thromb Vasc Biol. 2003;23(3):380\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"7013_CR43","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1432-2277.2009.01043.x","volume":"23","author":"CJ Sathya","year":"2010","unstructured":"Sathya CJ, Sheshgiri R, Prodger J, Tumiati L, Delgado D, Ross HJ, et al. Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients. Transpl Int. 2010;23(6):641\u20138.","journal-title":"Transpl Int"},{"issue":"2","key":"7013_CR44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/01.CIR.0000081703.34526.5D","volume":"108","author":"D Simper","year":"2003","unstructured":"Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation. 2003;108(2):143\u20139.","journal-title":"Circulation."},{"issue":"9","key":"7013_CR45","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI19628","volume":"113","author":"Y Hu","year":"2004","unstructured":"Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004;113(9):1258\u201365.","journal-title":"J Clin Invest"},{"issue":"2","key":"7013_CR46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCRESAHA.119.314855","volume":"125","author":"Z Ni","year":"2019","unstructured":"Ni Z, Deng J, Potter CMF, Nowak WN, Gu W, Zhang Z, et al. Recipient c-kit lineage cells repopulate smooth muscle cells of transplant arteriosclerosis in mouse models. Circ Res. 2019;125(2):223\u201341.","journal-title":"Circ Res"},{"issue":"9","key":"7013_CR47","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","volume":"12","author":"GG Sokos","year":"2006","unstructured":"Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP. Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail. 2006;12(9):694\u20139.","journal-title":"J Card Fail"},{"issue":"3","key":"7013_CR48","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/TP.0000000000002448","volume":"103","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang M, Hu X, Li Y, Ma D, Li S, et al. Liraglutide, a glucagon-like peptide-1 receptor agonist, attenuates development of cardiac allograft vasculopathy in a murine heart transplant model. Transplantation. 2019;103(3):502\u201311.","journal-title":"Transplantation."},{"issue":"1","key":"7013_CR49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3803\/EnM.2016.31.1.161","volume":"31","author":"J Bae","year":"2016","unstructured":"Bae J, Lee MJ, Choe EY, Jung CH, Wang HJ, Kim MS, et al. Effects of dipeptidyl peptidase-4 inhibitors on hyperglycemia and blood cyclosporine levels in renal transplant patients with diabetes: a pilot study. Endocrinol Metab (Seoul). 2016;31(1):161\u20137.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"7013_CR50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12933-014-0154-3","volume":"13","author":"Y Terawaki","year":"2014","unstructured":"Terawaki Y, Nomiyama T, Kawanami T, Hamaguchi Y, Takahashi H, Tanaka T, et al. Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury. Cardiovasc Diabetol. 2014;13:154.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"7013_CR51","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.healun.2015.11.002","volume":"35","author":"Y Yamada","year":"2016","unstructured":"Yamada Y, Jang JH, De Meester I, Baerts L, Vliegen G, Inci I, et al. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression. J Heart Lung Transplant. 2016;35(4):508\u201317.","journal-title":"J Heart Lung Transplant"},{"issue":"1\u20133","key":"7013_CR52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.vph.2011.05.001","volume":"55","author":"GP Fadini","year":"2011","unstructured":"Fadini GP, Avogaro A. Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vasc Pharmacol. 2011;55(1\u20133):10\u20136.","journal-title":"Vasc Pharmacol"},{"issue":"2","key":"7013_CR53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-9440(10)62266-3","volume":"166","author":"N Busso","year":"2005","unstructured":"Busso N, Wagtmann N, Herling C, Chobaz-Peclat V, Bischof-Delaloye A, So A, et al. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol. 2005;166(2):433\u201342.","journal-title":"Am J Pathol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07013-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-020-07013-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-020-07013-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T10:25:53Z","timestamp":1636453553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-020-07013-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7013"],"URL":"https:\/\/doi.org\/10.1007\/s10557-020-07013-w","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"4 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animals were treated according to protocols approved by the Institutional Animal Care Committee of the National Defense Medical Center (certificate Nos. IACUC-17-159 and IACUC-16-094). Experimental procedures and animal care conformed to the \u201cGuide for the Care and Use of Laboratory Animals\u201d published by the U.S. National Institutes of Health (NIH Publication No. 85\u201323, revised 1996).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Animals"}}]}}